Ardelyx Inc (ARDX) concluded trading on Wednesday at a closing price of $5.37, with 3.92 million shares of worth about $21.04 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -13.67% during that period and on Wednesday the price saw a gain of about 0.94%. Currently the company’s common shares owned by public are about 238.02M shares, out of which, 230.57M shares are available for trading.
Stock saw a price change of -1.29% in past 5 days and over the past one month there was a price change of -16.36%. Year-to-date (YTD), ARDX shares are showing a performance of 5.92% which decreased to -33.70% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.32 but also hit the highest price of $9.33 during that period. The average intraday trading volume for Ardelyx Inc shares is 4.09 million. The stock is currently trading 0.73% above its 20-day simple moving average (SMA20), while that difference is down -0.92% for SMA50 and it goes to -5.99% lower than SMA200.
Ardelyx Inc (NASDAQ: ARDX) currently have 238.02M outstanding shares and institutions hold larger chunk of about 63.54% of that.
The stock has a current market capitalization of $1.28B and its 3Y-monthly beta is at 0.77. It has posted earnings per share of -$0.17 in the same period. It has Quick Ratio of 4.31 while making debt-to-equity ratio of 0.89. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ARDX, volatility over the week remained 3.97% while standing at 5.65% over the month.
Stock’s fiscal year EPS is expected to drop by -37.08% while it is estimated to increase by 207.01% in next year.
Coverage by BTIG Research stated Ardelyx Inc (ARDX) stock as a Buy in their note to investors on March 04, 2025, suggesting a price target of $14 for the stock. On November 11, 2024, H.C. Wainwright Downgrade their recommendations, while on July 02, 2024, Piper Sandler Downgrade their ratings for the stock with a price target of $7. Stock get an Outperform rating from Leerink Partners on April 05, 2024.
